<DOC>
	<DOCNO>NCT02881060</DOCNO>
	<brief_summary>Objective : Because many people type 1 diabetes drink ethanol glucagon use treat mild hypoglycaemia , essential determine whether ethanol impair effectiveness glucagon increase glucose , may impair effectiveness dual hormone treatment prevent hypoglycaemia . The purpose study determine , whether ethanol influence glucose response subcutaneous glucagon mild hypoglycaemia . The investigator hypothesize prior evening ethanol consumption reduce effect glucagon bolus raise plasma glucose compare prior ethanol consumption . The study aim : 1 . To determine late effect ethanol efficacy subcutaneous glucagon restore plasma glucose episode mild hypoglycemia . 2 . To determine late effect ethanol counter-regulatory hormone hypoglycaemia awareness mild hypoglycaemia A double-blinded placebo-controlled study conduct . Participants serve control . Eligible participant informed consent complete two study visit , one one without ethanol consumption , random order . On study visit , participant induce insulin induced hypoglycemia , seven-eight hour meal without ethanol . Once plasma glucose 3.9 mmol/l , subcutaneous injection 100 mcg glucagon administer . Two hour later second bolus administer .</brief_summary>
	<brief_title>The Late Effects Ethanol Intake Glucose Response Subcutaneous Glucagon Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Age 18 70 year T1D ≥ 3 year BMI 2028 kg/m2 CSII ≥ 1 year Caucasian origin Hypoglycaemia awareness ( assessed Gold , Clarke PedersenBjergaard method ) Use carbohydrate counting insulin pump bolus calculator meal Ethanol exposure within 1 year consist least 4 drink ( 1 drink contains 12 gram ethanol ) within four hour Allergy intolerance lactose Glucagen® ( Novo Nordisk , Bagsværd , DK ) Allergy ethanol food ingredient use study . Impaired renal function ( eGFR &lt; 60 ml/min/1.73m2 ) Liver disease ALAT &gt; 2.5 time upper limit reference interval Gastropareses ( beatbeat variation &lt; 10 beat per min and/or orthostatic systolic blood pressure &gt; 20 mmHg ) Insomnia , sleep apnoea trouble sleep accord investigator 's assessment make individual unsuitable study participation . Aldehyde dehydrogenase deficiency determine screen questionnaire Unable refrain consumption ethanol least 24 hour prior study start History drinking problem alcoholism , regardless whether active remission . Use benzodiazepines barbiturate opiates central nervous system depressant drug could act synergistically ethanol low level consciousness History drug abuse Current participation another diabetesrelated clinical trial , judgment principle investigator , compromise result study safety subject . Use antidiabetic medicine ( insulin ) , corticosteroid drug affect glucose metabolism study period within 30 day prior study start Use medication know cause QT interval prolongation Presence pheochromocytoma Other concomitant medical psychological condition accord investigator 's assessment make individual unsuitable study participation Females pregnant , breastfeed intend become pregnant use adequate contraceptive method . Females different basal insulin pattern depend menstrual cycle . Inability understand individual information give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Glucagon</keyword>
	<keyword>Ethanol</keyword>
</DOC>